Jove
Visualize
Contáctanos
JoVE
x logofacebook logolinkedin logoyoutube logo
ACERCA DE JoVE
Visión GeneralLiderazgoBlogCentro de Ayuda JoVE
AUTORES
Proceso de PublicaciónConsejo EditorialAlcance y PolíticasRevisión por ParesPreguntas FrecuentesEnviar
BIBLIOTECARIOS
TestimoniosSuscripcionesAccesoRecursosConsejo Asesor de BibliotecasPreguntas Frecuentes
INVESTIGACIÓN
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchivo
EDUCACIÓN
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualCentro de Recursos para ProfesoresSitio de Profesores
Términos y Condiciones de Uso
Política de Privacidad
Políticas

Videos de Conceptos Relacionados

Protein Kinases and Phosphatases02:54

Protein Kinases and Phosphatases

15.2K
Proteins undergo chemical modifications that trigger changes in the charge, structure, and conformation of the proteins. Phosphorylation, acetylation, glycosylation, nitrosylation, ubiquitination, lipidation, methylation, and proteolysis are various protein modifications that regulate protein activity. Such modifications are usually enzyme-driven.
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
15.2K
Protein Kinases and Phosphatases02:54

Protein Kinases and Phosphatases

4.5K
4.5K
Protein Complex Assembly02:41

Protein Complex Assembly

16.8K
Proteins can form homomeric complexes with another unit of the same protein or heteromeric complexes with different types.  Most protein complexes self-assemble spontaneously via ordered pathways, while some proteins need assembly factors that guide their proper assembly. Despite the crowded intracellular environment, proteins usually interact with their correct partners and form functional complexes.
Many viruses self-assemble into a fully functional unit using the infected host cell to...
16.8K
Protein Complexes with Interchangeable Parts01:57

Protein Complexes with Interchangeable Parts

2.9K
Groups of proteins may form a complex where each protein in this complex has a different role in the overall execution of the complex’s function. Often some of the proteins in the complex can be replaced by a closely related variant to give a complex that contains many of the same components yet is functionally distinct.
The SCF ubiquitin ligase is a protein complex of five individual proteins. This complex attaches ubiquitin to other target proteins to mark them for degradation. In order...
2.9K
Complex Numbers01:29

Complex Numbers

317
The real number system cannot represent the square root of a negative number, which restricts solutions for certain equations, such as quadratics with negative discriminants. To address this, the complex number system was developed, introducing the imaginary unit i, where i = √(-1). This extension allows for the representation of all roots, including those involving negative radicands.A complex number is written in the form x + yi, where x and y are real numbers. Here, x represents the...
317
Formation of Complex Ions03:45

Formation of Complex Ions

26.2K
A type of Lewis acid-base chemistry involves the formation of a complex ion (or a coordination complex) comprising a central atom, typically a transition metal cation, surrounded by ions or molecules called ligands. These ligands can be neutral molecules like H2O or NH3, or ions such as CN− or OH−. Often, the ligands act as Lewis bases, donating a pair of electrons to the central atom. These types of Lewis acid-base reactions are examples of a broad subdiscipline called coordination...
26.2K

También podría leer

Artículos Relacionados

Artículos vinculados a este trabajo por autores compartidos, revista y gráfico de citas.

Ordenar por
Same author

<i>LRRK2</i> in Focus: A Global Browser Linking Genetic Diversity to Functional Effects.

medRxiv : the preprint server for health sciences·2026
Same author

Large-scale functional annotation establishes a reference framework for human <i>LRRK2</i> variants.

medRxiv : the preprint server for health sciences·2026
Same author

Addressing the Challenges of Translating LRRK2 Biology into Disease-Modifying Therapies: The LRRK2 Investigative Therapeutics Exchange Initiative.

Movement disorders : official journal of the Movement Disorder Society·2026
Same author

Elucidating the molecular interplay between LRRK2 and Rab GTPases.

bioRxiv : the preprint server for biology·2026
Same author

Ex Vivo LRRK2 Activation in Asian G2385R and R1628P Variant Carriers and Idiopathic Parkinson's Disease.

Movement disorders : official journal of the Movement Disorder Society·2026
Same author

Variants in the proteasome regulator PSMF1 cause a phenotypic spectrum from parkinsonism to perinatal lethality.

Nature communications·2026

Video Experimental Relacionado

Updated: Feb 6, 2026

Author Spotlight: Developing Tools to Tune the Activity of Tyrosine Phosphatases
06:56

Author Spotlight: Developing Tools to Tune the Activity of Tyrosine Phosphatases

Published on: September 6, 2024

815

Los complejos de la fosfatasa PP1: ya no son farmacológicos

Paola Vagnarelli1, Dario R Alessi2

  • 1College of Health and Life Science, Research Institute for Environment Health and Society, Brunel University London, London UB8 3PH, UK.

Cell
|August 25, 2018
PubMed
Resumen

Los investigadores identificaron Raphin1, un nuevo inhibidor de la subunidad reguladora R15B de la proteína fosfatasa 1 (PP1) de serina y treonina. Este descubrimiento ofrece una nueva forma de dirigirse a las fosfatasas, mostrando una promesa en la protección de las células del estrés y la neurodegeneración.

Más Videos Relacionados

Concanavalin A-Based Sedimentation Assay to Measure Substrate Binding of Glucan Phosphatases
09:07

Concanavalin A-Based Sedimentation Assay to Measure Substrate Binding of Glucan Phosphatases

Published on: December 23, 2022

1.8K
A Mass Spectrometry-Based Approach to Identify Phosphoprotein Phosphatases and their Interactors
10:17

A Mass Spectrometry-Based Approach to Identify Phosphoprotein Phosphatases and their Interactors

Published on: April 29, 2022

2.9K

Videos de Experimentos Relacionados

Last Updated: Feb 6, 2026

Author Spotlight: Developing Tools to Tune the Activity of Tyrosine Phosphatases
06:56

Author Spotlight: Developing Tools to Tune the Activity of Tyrosine Phosphatases

Published on: September 6, 2024

815
Concanavalin A-Based Sedimentation Assay to Measure Substrate Binding of Glucan Phosphatases
09:07

Concanavalin A-Based Sedimentation Assay to Measure Substrate Binding of Glucan Phosphatases

Published on: December 23, 2022

1.8K
A Mass Spectrometry-Based Approach to Identify Phosphoprotein Phosphatases and their Interactors
10:17

A Mass Spectrometry-Based Approach to Identify Phosphoprotein Phosphatases and their Interactors

Published on: April 29, 2022

2.9K

Área de la Ciencia:

  • La bioquímica
  • Farmacología
  • La neurociencia

Sus antecedentes:

  • Los inhibidores de la quinasa son comunes, pero la focalización de las fosfatasas para el desarrollo de fármacos es menos explorada.
  • La proteína serina/treonina fosfatasa 1 (PP1) tiene subunidades reguladoras que controlan su función.
  • La desregulación de la actividad de PP1 está implicada en varias enfermedades, incluidos los trastornos neurodegenerativos.

Objetivo del estudio:

  • Identificar y caracterizar nuevos inhibidores de las subunidades reguladoras de PP1.
  • Explorar el potencial terapéutico de dirigirse a las subunidades reguladoras de PP1 para la neuroprotección.

Principales métodos:

  • Evaluación química para identificar los inhibidores de las subunidades reguladoras de PP1.
  • Ensayos bioquímicos para confirmar la selectividad y la potencia del inhibidor.
  • Ensayos basados en células para evaluar la protección celular contra el estrés.
  • Estudios in vivo con un modelo de ratón de la enfermedad de Huntington.

Principales resultados:

  • Identificación de Raphin1, un inhibidor selectivo de la subunidad reguladora PP1 R15B.
  • Raphin1 demostró su eficacia en la protección de las células contra diversos factores estresantes.
  • El tratamiento con Raphin1 retrasó la neurodegeneración en un modelo de ratón de la enfermedad de Huntington.

Conclusiones:

  • Dirigirse a las subunidades reguladoras de PP1, específicamente R15B con Raphin1, representa una estrategia farmacológica viable.
  • Raphin1 muestra potencial terapéutico para el tratamiento de enfermedades neurodegenerativas como el Huntington.
  • Este trabajo expande el alcance de la regulación farmacológica más allá de las quinasas a las fosfatasas.